Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-26-075282

Director acquired 3,135 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
HENNEMAN JOHN B III Director 2026-06-16 Grant or award +3,135 13,364 D
Derivatives
HENNEMAN JOHN B III Director 2026-06-16 Grant or award · Stock Options (Right to Buy) +12,555 12,555 D
Loading xslF345X06/tm2618211-5_4seq1.xml…